Family Study in Schizophrenia

NCT ID: NCT00418912

Last Updated: 2008-02-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-03-31

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Schizophrenia is a severe mental illness which is considered to have, among other, a genetic etiology. One of the most efficient tools in genetic-psychiatry is the investigation of multiplex families.

The current study will identify patients of multiplex families and to map their family connections and the presence of mental illnesses among family members.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia Family Genetics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

FAMILY_BASED

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Schizophrenia
2. Multiplex family
3. Able to understand and sign the informed concent form.
4. Hebrew speaker
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sheba Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mental Health Epidemiology, The Gertner Institute for Epidemiology

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raz Gross, MD

Role: PRINCIPAL_INVESTIGATOR

Mental Health Epidemiology & Psychosocial Aspects of Illness, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer , Israel

Michael Bunzel, MD

Role: STUDY_DIRECTOR

Psychiatric Unit, Sheba Medical Center, Tel Hashomer, Israel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Psychiatric unit, Sheba Medical Center

Tel Litwinsky, , Israel

Site Status RECRUITING

Seba Medical Center

Tel Litwinsky, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Raz Gross, MD

Role: CONTACT

972-3-5303962

Michael Bunzel, MD

Role: CONTACT

972-3-530

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Michael Bunzel, MD

Role: primary

Michael Bunzel, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHEBA-06-4329-RG-CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Schizophrenia Imaging
NCT01655472 UNKNOWN NA
Microglia Activation in Schizophrenia
NCT00205608 COMPLETED PHASE1